Advanced Search

Amendment Statement of Principles concerning diabetes mellitus No. 89 of 2014

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
Amendment Statement of Principles
concerning
 
DIABETES MELLITUS
No. 89 of 2014
 
for the purposes of the
 
Veterans’ Entitlements Act 1986
and
Military Rehabilitation and Compensation Act 2004
1.                     This Instrument may be cited as Amendment Statement of Principles concerning diabetes mellitus No. 89 of 2014.
2.                     The Repatriation Medical Authority amends, under subsection 196B(8) of the Veterans’ Entitlements Act 1986, Statement of Principles concerning diabetes mellitus Instrument No. 90 of 2011, by:
(A)             Replacing factors "(f)" and "(n)" in clause 6 as follows:
"(f)         being treated with a drug or a drug from a class of drugs from specified list 1 at the time of the clinical onset of diabetes mellitus; or";
"(n)        being treated with a drug or a drug from a class of drugs from specified list 1 at the time of the clinical worsening of diabetes mellitus; or";
(B)              Inserting new factor "(fa)" following factor "(f)" in clause 6 as follows:
"(fa)       being treated with a drug or a drug from a class of drugs from specified list 3, which cannot be ceased or substituted, for at least the three months before the clinical onset of diabetes mellitus; or";
(C)              Inserting new factor "(na)" following factor "(n)" in clause 6 as follows:
"(na)       being treated with a drug or a drug from a class of drugs from specified list 3, which cannot be ceased or substituted, for at least the three months before the clinical worsening of diabetes mellitus; or";
(D)             Inserting definitions of "a drug or a drug from a class of drugs from specified list 1" and "a drug or a drug from a class of drugs from specified list 3" in alphabetical order in clause 9 as follows:
'"a drug or a drug from a class of drugs from specified list 1" means:
(a)                beta-blockers;
(b)               gonadotrophin-releasing hormone (GnRH) agonists;
(c)                pentamidine;
(d)               protease inhibitors;
(e)                stavudine;
(f)                streptozotocin;
(g)               thiazide diuretics; or
(h)               zidovudine;';
'"a drug or a drug from a class of drugs from specified list 3" means:
(a)                antidepressants;
(b)               chlorpromazine;
(c)                clozapine;
(d)               fluphenazine;
(e)                haloperidol; 
(f)                levomepromazine;
(g)               olanzapine; 
(h)               perphenazine;
(i)                 quetiapine;
(j)                 risperidone; 
(k)               sertindole;
(l)                 thioridazine;
(m)             zotepine; or
(n)               zuclopenthixol;';
(E)              Replacing the definition of "relevant service" in clause 9 as follows:
'"relevant service" means:
(a)               eligible war service (other than operational service) under the VEA;
(b)               defence service (other than hazardous service and British nuclear test defence service) under the VEA; or
(c)               peacetime service under the MRCA;'; and
(F)               Deleting the definition of "a drug or a drug from a class of drugs from the specified list" in clause 9.
3.                     The amendments made by this instrument apply to all matters to which Instrument No. 90 of 2011, section 120B of the Veterans’ Entitlements Act 1986 and section 339 of the Military Rehabilitation and Compensation Act 2004 apply.
4.                     The amendments made by this instrument take effect from 22 September 2014.
Dated this   twenty-second   day of   August   2014
The Common Seal of the                    )
Repatriation Medical Authority          )
was affixed at the direction of:          )
PROFESSOR NICHOLAS SAUNDERS AO
CHAIRPERSON